Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma.
Cancers (Basel). 2021 Nov 21;13(22):5839. doi: 10.3390/cancers13225839.
Cancers (Basel). 2021.
PMID: 34830992
Free PMC article.
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS, Oswald AJ, Stillie LJ, Croy I, Churchman M, Hollis RL.
Herrington CS, et al. Among authors: stillie lj.
Br J Cancer. 2024 Feb;130(2):327-335. doi: 10.1038/s41416-023-02508-3. Epub 2023 Dec 14.
Br J Cancer. 2024.
PMID: 38097740
Free PMC article.
Item in Clipboard
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.
Hollis RL, Elliott R, Dawson JC, Ilenkovan N, Matthews RM, Stillie LJ, Oswald AJ, Kim H, Llaurado Fernandez M, Churchman M, Porter JM, Roxburgh P, Unciti-Broceta A, Gershenson DM, Herrington CS, Carey MS, Carragher NO, Gourley C.
Hollis RL, et al. Among authors: stillie lj.
Gynecol Oncol. 2024 Apr 5;186:42-52. doi: 10.1016/j.ygyno.2024.03.029. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38582027
Free article.
Item in Clipboard
Cite
Cite